VentriPoint Diagnostics Ltd. VPT.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 106.70K | 92.90K | 128.50K | 125.40K | 97.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 106.70K | 92.90K | 128.50K | 125.40K | 97.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 106.70K | 92.90K | 128.50K | 125.40K | 97.00K |
| SG&A Expenses | 1.56M | 2.04M | 2.30M | 2.44M | 2.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.83M | 2.30M | 2.56M | 2.78M | 3.16M |
| Operating Income | -1.72M | -2.21M | -2.43M | -2.65M | -3.06M |
| Income Before Tax | -1.70M | -2.15M | -2.33M | -2.96M | -3.33M |
| Income Tax Expenses | -37.40K | -37.40K | -37.40K | -59.60K | -59.60K |
| Earnings from Continuing Operations | -1.66 | -2.11 | -2.29 | -2.90 | -3.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.66M | -2.11M | -2.29M | -2.90M | -3.27M |
| EBIT | -1.72M | -2.21M | -2.43M | -2.65M | -3.06M |
| EBITDA | -998.20K | -1.84M | -2.43M | -2.65M | -3.06M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 708.79M | 681.78M | 657.61M | 650.90M | 641.10M |
| Average Diluted Shares Outstanding | 708.79M | 681.78M | 657.61M | 650.90M | 641.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |